Theranos founder Elizabeth Holmes has reportedly gotten married in a secret wedding — here's what we know about her hotel-heir husband, William 'Billy' Evans

Learn more about BI Prime View online           Science Select           Theranos founder Elizabeth Holmes has reportedly gotten married in a secret wedding — here's what we know about her hotel-heir husband, William 'Billy' Evans   Theranos founder Elizabeth Holmes keeps her private life private. But here's what we know about her husband, a 27-year-old heir to Evans Hotel Group.   READ MORE           Elizabeth Holmes is reportedly married. Here's a timeline of the Theranos CEO's rise and fall, from becoming the world's youngest female billionaire to getting charged with massive fraud   Elizabeth Holmes started blood-testing startup Theranos at 19, and grew it to a $9 billion valuation. Then she was charged with massive fraud.   READ MORE           More than 30 years after the Chernobyl disaster, no people can live in the area — but the animal population is thriving   Animals have taken over the area surrounding the Chernobyl nuclear power plant. There are no humans to stand in their way.   READ MORE             Chernobyl was the world's worst nuclear-power-plant accident. Here's how it compares with Fukushima and Three Mile Island.   Chernobyl is widely acknowledged to be the worst nuclear disaster in history, but a few scientists have argued that Fukushima was more destructive.   READ MORE           Researchers came up with a medical glue gun to replace stitches where the 'glue' peels off once the skin is heeled   The melted polymer works both externally and internally, and is non-toxic, flexible and biodegradable, according to researchers.   READ MORE           The EPA says a chemical in Monsanto's weed-killer doesn't cause cancer — but there's compelling evidence the agency is wrong   The weed-killer glyphosate is a contentious chemical. Agencies dispute whether it causes cancer in humans, but we have some evidence that it does.   READ MORE           3 biotechs that investors should buy next after Pfizer's $11 billion deal for cancer drugmaker Array BioPharma   Several other biotechs are also developing "targeted" cancer drugs that aim to better fight the disease.   READ MORE           A dangerous flesh-eating bacteria is gaining a larger foothold in the US as the oceans warm   A flesh-eating infection that spreads via contact with raw shellfish is spreading into a larger region of the US due to warming ocean waters.   READ MORE           23 'facts' you learned about healthy eating and nutrition as a kid that are no longer true   Low-fat foods aren't better for you, it's alright to skip breakfast, and your pee need not be clear.   READ MORE           Pfizer just struck an $11 billion deal, and it marks an ambitious shift in the US drug giant's blockbuster cancer strategy   Pfizer is buying the biotech Array BioPharma for $11 billion. Array makes 'targeted' cancer drugs designed to do a better job of fighting the disease.   READ MORE           Was this email forwarded to you? SUBSCRIBE NOW     Share this     You received this email because you signed up to this Business Insider newsletter using the email: nguyenvu1187.love5@blogger.com   Email preferences Unsubscribe TERMS OF SERVICE PRIVACY POLICY 1 Liberty Plaza, 8th Floor. New York, NY 10006